Jun Li
Head Of Oncology GemPharmatech
Seminars
Wednesday 2nd December 2026
Precision Preclinical Model Selection for Modern Cancer Immunotherapy
1:50 pm
- Why conventional murine models fail to recapitulate human immune–tumour interactions
- Matching therapeutic modalities to purpose-built humanized immune architectures
- Leveraging translational services to de-risking clinical translation and Go/No-Go decisions
Wednesday 2nd December 2026
Insights Exchange – How Should Teams Select the Right Model Under Real World Constraints?
2:40 pm
- What characteristics consistently appear in models that successfully predict patient outcomes?
- Where do models most commonly fail despite encouraging preclinical data?
- Which translational endpoints should teams prioritise when evaluating model performance
- Audience Q&A